. 2020 Apr 24;5(17):10145–10159. doi: 10.1021/acsomega.0c00865
Copyright © 2020 American Chemical
Society
This is an open access article published under a Creative Commons Non-Commercial No Derivative Works (CC-BY-NC-ND) Attribution License, which permits copying and redistribution of the article, and creation of adaptations, all for non-commercial purposes.
Figure 2.
Some reported examples of GyrB/ParE inhibitors.